Mammoth Biosciences
Healthcare AI
Diagnostics and gene-editing therapeutics
Series D
Mammoth Biosciences is a biotechnology company developing next-generation CRISPR-based in vivo gene-editing therapeutics and diagnostics, using proprietary ultra-compact CRISPR systems and AI-powered screening to enable potential one-time curative therapies and multiplex disease detection across a broad range of conditions.
Company Details
- Website
- mammoth.bio
- Headquarters
- Brisbane, California, USA
- Founded
- 2017
- Funding
- $379M
Subscriber Intelligence
- • Deal signal alerts for this company
- • Sentiment & risk scoring
- • Competitive framework analysis
- • Regulatory event monitoring